Mark J. Tarr, chief executive officer of Encompass Health Corp ($EHC), sold 171,569 shares of company stock on August 10, 2026, at a price of $125.46 per share, according to a Form 4 filed with the Securities and Exchange Commission on August 11. The open-market transaction was valued at $21,525,047. On the same day, Tarr sold an additional 1,579 shares at $126.06 per share, bringing his total sales for August 10 to approximately $21.7 million.
Following both transactions, Tarr held 267,814 shares of Encompass Health directly. The shares sold represented roughly 39 percent of his direct holdings prior to the sales.
Tarr was not the only Encompass Health executive to report a sale on August 10. Chief financial officer Douglas E. Coltharp sold 18,869 shares at an average price of $125.38 per share, for a total of $2,365,795. John Patrick Darby, a vice president, sold 8,906 shares at $125.95 per share, for $1,121,711. Across the three insiders, the combined value of August 10 sales reached approximately $25.2 million.
The transactions followed a sharp rise in Encompass Health's stock price. $EHC closed at $110.50 on August 4 and reached $125.81 by the close on August 10, a gain of roughly 14 percent over four trading sessions. Tarr's larger sale was executed at $125.46, near the upper end of the day's range of $124.00 to $126.64.
Tarr has been a regular seller of Encompass Health shares in 2026. On February 11, he executed seven open-market sales totaling approximately $16.75 million, at prices ranging from $108.03 to $113.58 per share. Combined with the August 10 sales, Tarr has sold roughly $38.5 million worth of $EHC stock across those two dates in 2026. Unlike the February sales, which involved only Tarr, the August 10 sales included multiple C-suite participants.
Encompass Health, headquartered in Birmingham, Alabama, operates inpatient rehabilitation hospitals across the United States. The company had a market capitalization of approximately $12.4 billion at the time of the trades.
No members of Congress have disclosed trades in $EHC during 2026. The most recent congressional activity in the stock came from Representative Lisa Mcclain, Republican of Michigan, who reported several small purchases and sales in the second half of 2025. Earlier congressional trades in $EHC included transactions by Representatives Ro Khanna (D-CA), Susie Lee (D-NV), and Peter Meijer (R-MI).